Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Actelion
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed patient informed consent form (ICF).
Patients ≥ 18 years of age at time of Uptravi initiation, and
Patients who initiate Uptravi:
* at enrollment, or
* less than or equal to 60 days prior to enrollment and have a documented titration regimen (defined as all documented dose changes including, but not limited to: starting dose and dates and highest tolerated dose and dates)
You may not be if
Patients previously exposed to Uptravi treatment during a clinical trial.
Patients that previously discontinued Uptravi for any reason, prior to study enrollment (discontinuation defined as an interruption of therapy greater than or equal to 30 days).
Patients enrolled in a blinded clinical trial or in a clinical trial involving an unapproved drug.
Clareo Health | A Registry for Patients Taking Uptravi
